FVC First Venture Capital Corp -
FVC responds to BC College of Physicians and Surgeons report
FVC First Venture Capital Corp FVCShares issued 4,000,0001999-02-18 close $2.35Friday Feb 19 1999Mr. Stuart Ross reports The company issued a corporate update, including a response to a report by the B.C. College of Physicians and Surgeons regarding the sands of Sahara syndrome as it relates to the company's proposed acquisition of Lasik Vision Canada. Response to College Report As the College reports, surgeons in the laser eye surgery industry are increasingly becoming aware of a post-operative condition known as sands of Sahara syndrome, which is a non-infectious inflammation within the cornea following the Lasik surgery procedure. The company has experienced several occurrences of sands at the surgery clinics in Canada. In all cases, these occurrences were stopped within days of the first cases noted. The company has managed the sands condition successfully and experienced a relatively low incidence rate primarily because in-house professionals who are highly skilled in detecting the earliest symptoms of sands perform post-operative care at Lasik Vision clinics. After the condition is successfully treated, it does not generally reoccur. The company is working alongside laser eye surgery professionals across North America to determine the exact causes of sands, which, at this time, are not known. Medical research on probable causes is focusing on the medications and solutions used during and after surgery as well as the cleaning and sterilization techniques for the lasers used in surgery. The company is also cooperating closely with the B.C. College of Physicians and Surgeons in an industry-wide surveillance program to monitor the sands condition. In addition, all Lasik Vision patients are informed of the sands syndrome in the consent forms that patients must sign before surgery. Business Expansion The company is embarking on an aggressive strategy of expansion through new clinic openings. In addition to centres in Toronto, Vancouver, Montreal, Calgary and Ottawa, the company plans to open several new clinics in major Canadian cities, including Halifax and Quebec City, in the first quarter of 1999. WARNING: The company relies upon litigation procedure for "forward-looking" statements. (c) Copyright 1999 Canjex Publishing Ltd. canada-stockwatch.com
old url (better for printing) |
